OraSure Technologies Inc specializes in innovative diagnostic tests and collection devices across a broad range of health conditions and industries. With a focus on ease of use and rapid results, its products include solutions for detecting HIV, COVID-19, hepatitis C, and Ebola, as well as devices for drug and alcohol testing. The company also ventures into genomic services with saliva-based DNA collection kits and supports gut microbiome research through specialized collection and analysis tools. Serving a global market, OraSure aims to improve public health and personal wellness by making diagnostics accessible and straightforward.
Wednesday afternoon's analyst upgrades and downgrades included AutoZone, BHP, Cidara Therapeutics, Magnite and ZIM Integrated Shipping Services.
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
OraSure Technologies shares jumped to start off the week after the company announced an update from the FDA in regards to its COVID-19 test kit.
Chris Lange Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Alibaba, Concho Resources, Occidental Petroleum, Palo Alto Networks, Salesforce.com, Splunk, Uber and Workday.
Monday's top analyst upgrades and downgrades included Albermarle, Apple, Consolidated Edison, Etsy, GoHealth, Hecla Mining, NortonLifeLock, Pinterest, Switch and T-Mobile.
